PARP inhibitor resistance: the underlying mechanisms and clinical implicationsHe Li, Jing Wang|Molecular Cancer|2020Cited by 527
SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathwayYing Wang, Jing Wang|Medical Oncology|2023Cited by 32